Improvements in population-based survival of patients presenting with metastatic rectal cancer in the south of the Netherlands, 1992-2008

Clinical and Experimental Metastasis

Volumn 28, Issue 3, 2011, Pages 283-290

  Lemmens, V E P P ^a,b   De Haan, N ^c   Rutten, H J T ^c   Martijn, H ^d   Loosveld, O J L ^e   Roumen, R M H ^f   Creemers, G J M ^c  

^a The Netherlands   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d Hospital   (Netherlands)

^e AMPHIA HOSPITAL   (Netherlands)

^f MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapy; Metastases; Population based cancer registries; Rectal cancer; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS RESECTION; NETHERLANDS; OVERALL SURVIVAL; RECTUM CANCER; HISTORY; MIDDLE AGED; MORTALITY; PROGNOSIS; RECTUM TUMOR; REGISTER; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; RECTAL NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79953312311     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9370-8     Document Type: Article

References (30)

1. IKCnet (2010) Dutch Comprehensive Cancer centres. http:// www.ikcnet.nl
2. Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
3. Elferink MA, van Steenbergen LN, Krijnen P et al (2010) Marked improvements in survival of patients with rectal cancer in the Netherlands following changes in therapy, 1989-2006. Eur J Cancer 46:1421-1429
4. Simmonds PC (2000) Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 321:531-535
5. Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476-487
6. Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041-1047 (Pubitemid 30162806)
7. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947 (Pubitemid 30644117)
8. Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342 (Pubitemid 38702844)
9. Kabbinavar FF, Hambleton J, Mass RD et al (2005) Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/ leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 23:3706-3712
10. Jonker DJ, O'Callaghan CJ, Karapetis CS et al (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040-2048 (Pubitemid 350106711)
11. Tol J, Koopman M, Cats A et al (2009) Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 360:563-572
12. Meulenbeld HJ, van Steenbergen LN, Janssen-Heijnen ML et al (2008) Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004. Ann Oncol 19:1600-1604
13. Meguid RA, Slidell MB, Wolfgang CL et al (2008) Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol 15:2388-2394
14. Fritz A, Percy C, Jack A et al (2000) International classification of diseases for oncology. World Health Organization, Geneva
15. UICC (2002) TNM classification of malignant tumours. Wiley- Liss, New York
16. Koopman M, Antonini NF, Douma J et al (2007) Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 370:135-142 (Pubitemid 47042893)
17. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383 (Pubitemid 17055592)
18. Lemmens VE, Janssen-Heijnen ML, Verheij CD et al (2005) Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 92:615-623 (Pubitemid 40685658)
19. Lemmens VE, van Halteren AH, Janssen-Heijnen ML et al (2005) Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 16:767-772 (Pubitemid 40767098)
20. Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604-1608 (Pubitemid 15062653)
21. Glebov OK, Rodriguez LM, Nakahara K et al (2003) Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 12:755-762 (Pubitemid 36993166)
22. Li FY, Lai MD (2009) Colorectal cancer, one entity or three. J Zhejiang Univ Sci 10:219-229
23. Chiappa A, Makuuchi M, Lygidakis NJ et al (2009) The management of colorectal liver metastases: expanding the role of hepatic resection in the age of multimodal therapy. Crit Rev Oncol Hematol 72:65-75
24. Ruers T, Bleichrodt RP (2002) Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38:1023-1033 (Pubitemid 34442330)
25. Poston GJ, Adam R, Alberts S et al (2005) OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol 23:7125-7134
26. Nordlinger B, Benoist S (2006) Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol 24:4954-4955 (Pubitemid 46631395)
27. Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14(2): ii13-ii16 (Pubitemid 36874133)
28. Reddy SK, Barbas AS, Clary BM (2009) Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management? Ann Surg Oncol 16:2395-2410
29. Scheer MG, Sloots CE, van der Wilt GJ et al (2008) Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol 19:1829-1835
30. Temple LK, Hsieh L, Wong WD et al (2004) Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol 22:3475-3484 (Pubitemid 41103653)